This Article Full Text Full Text (PDF) All Versions of this Article: 92/11/4123    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pecori Giraldi, F. Articles by Cavagnini, F. Search for Related Content PubMed PubMed Citation Articles by Pecori Giraldi, F. Articles by Cavagnini, F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cushing's Syndrome Hazardous Substances DB DEXAMETHASONE HYDROCORTISONE Related Collections Adrenal and Hypertension

Specificity of First-Line Tests for the Diagnosis of Cushing’s Syndrome: Assessment in a Large Series

Chair of Endocrinology, University of Milan, Ospedale San Luca, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, I-20149 Milan, Italy

Address all correspondence and requests for reprints to: Professor Francesco Cavagnini, Chair of Endocrinology, University of Milan, Ospedale San Luca, via Spagnoletto 3, I-20149 Milan, Italy. E-mail: cavagnini{at}auxologico.it.

Context: The diagnosis of Cushing’s syndrome requires highly sensitive screening tests. Therefore, diagnostic cutoffs have been lowered to maximize sensitivity and identify all patients. However, few studies have investigated the impact of these refinements on the specificity of first-line tests.

Objective: The aim of the study was the assessment of the specificity of three widely used screening tests in a large series of Cushing’s syndrome suspects referred to our endocrine service.

Patients: We retrospectively reviewed the results of urinary free cortisol (UFC), 1-mg dexamethasone suppression test [overnight suppression test (OST)], and serum cortisol at midnight in 3461, 357, and 864 patients, respectively, with clinical features suggestive of Cushing’s syndrome but in whom this diagnosis was subsequently excluded.

Results: UFC and OST at the 5-µg/dl cutoff exhibited the highest specificities [91% (95% confidence intervals [CI] 90.2–92.1%) and 97% (95% CI 96.3–98.5%), respectively]. Conversely, midnight serum cortisol yielded 87% (95% CI 84.3–91.1%) specificity only with the 7.5-µg/dl cutoff, whereas the 1.8-µg/dl threshold resulted in an unacceptably high proportion of false positives at only 20% specificity (95% CI 16.0–24.4%). Gender and age may lead to misleading results in all three screening tests.

Conclusions: Specificity of tests for Cushing’s syndrome varies considerably, with OST and UFC presenting the best performances, and circadian rhythm appearing heavily impaired by lowering of diagnostic cutoffs. Indeed, the vast majority of individuals in our series presented midnight serum cortisol values greater than 1.8 µg/dl; thus, caution has to be exercised when this criterion is used to exclude Cushing’s syndrome.

This article has been cited by other articles:

				M. Misra, M. A. Bredella, P. Tsai, N. Mendes, K. K. Miller, and A. Klibanski Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E385 - E392. [Abstract] [Full Text] [PDF]

				L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540. [Abstract] [Full Text] [PDF]

				M. B. Elamin, M. H. Murad, R. Mullan, D. Erickson, K. Harris, S. Nadeem, R. Ennis, P. J. Erwin, and V. M. Montori Accuracy of Diagnostic Tests for Cushing's Syndrome: A Systematic Review and Metaanalyses J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1553 - 1562. [Abstract] [Full Text] [PDF]